RecallRadar

FDA Device recall Z-1946-2018

Syva¿ EMIT¿ 2000 Theophylline Product Usage: The Syva¿ Emit¿ 2000 Theophylline Assay is a homogeneous enzyme immunoassay intended for use i…

On 2018-06-06 the FDA classified a Class II recall of Syva¿ EMIT¿ 2000 Theophylline Product Usage: The Syva¿ Emit¿ 2000 Theophylline Assay is a homogeneous enzyme immunoassay intended for use i… by Siemens Healthcare Diagnostics, citing lot J1 of the Syva¿ EMIT¿ 2000 Theophylline Assay, when run on a Beckman AU Clinical Chemistry System, may exhibit increased imprecision for commercially available controls and fo….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1946-2018
ClassificationClass II
Statusterminated
Initiated2017-11-27
Published2018-06-06
Last updated2026-09-13 11:54 UTC
CompanySiemens Healthcare Diagnostics
DistributionUS

Product

Syva¿ EMIT¿ 2000 Theophylline Product Usage: The Syva¿ Emit¿ 2000 Theophylline Assay is a homogeneous enzyme immunoassay intended for use in the quantitative analysis of theophylline in human serum or plasma.

Reason

Lot J1 of the Syva¿ EMIT¿ 2000 Theophylline Assay, when run on a Beckman AU Clinical Chemistry System, may exhibit increased imprecision for commercially available controls and for patient samples.

Identifiers

code_infoCatalog # 4P019UL /SMN#10445324 kit lot J1 (UDI# 00842768001024J120190414)

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1946-2018%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.